scholarly article | Q13442814 |
P50 | author | Jason A. Papin | Q37369558 |
Glynis L Kolling | Q56888940 | ||
Cirle Alcantara Warren | Q62070954 | ||
P2093 | author name string | Erik L Hewlett | |
Mary C Gray | |||
Gina M Donato | |||
Kevin M D'Auria | |||
P2860 | cites work | Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters | Q36961946 |
Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection | Q36999988 | ||
Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc | Q37025852 | ||
Effects of Clostridium difficile toxins given intragastrically to animals | Q37074797 | ||
The economic burden of Clostridium difficile | Q37147648 | ||
Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. | Q37358133 | ||
Economic healthcare costs of Clostridium difficile infection: a systematic review | Q37691876 | ||
The enterotoxicity of Clostridium difficile toxins | Q37954308 | ||
Clostridium difficile toxin A induces expression of the stress-induced early gene product RhoB. | Q38334527 | ||
Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome | Q39713999 | ||
gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A. | Q39757721 | ||
Comparison of two toxins produced by Clostridium difficile | Q40612560 | ||
Tissue eosinophilia in a mouse model of colitis is highly dependent on TLR2 and independent of mast cells. | Q42045236 | ||
Expression of the regeneration-associated protein SPRR1A in primary sensory neurons and spinal cord of the adult mouse following peripheral and central injury. | Q42140145 | ||
Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells | Q47936620 | ||
Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding | Q49187253 | ||
Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis. | Q51024811 | ||
Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. | Q51626531 | ||
Fatal enterocolitis in hamsters given lincomycin hydrochloride. | Q54693976 | ||
Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters | Q67697866 | ||
A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon | Q71884807 | ||
Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice | Q77718421 | ||
Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques | Q86073305 | ||
Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells | Q24561508 | ||
Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit | Q24607564 | ||
Toxin B is essential for virulence of Clostridium difficile | Q24647539 | ||
Exploration, normalization, and summaries of high density oligonucleotide array probe level data | Q27861098 | ||
An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers | Q28508414 | ||
A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes | Q29618085 | ||
Immune responses to Clostridium difficile infection | Q30416692 | ||
Systems analysis of the transcriptional response of human ileocecal epithelial cells to Clostridium difficile toxins and effects on cell cycle control | Q30428655 | ||
Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain | Q30429490 | ||
Epithelial cell apoptosis facilitates Entamoeba histolytica infection in the gut | Q30433009 | ||
Angiotensin II subtype 1 receptor blockade inhibits Clostridium difficile toxin A-induced intestinal secretion in a rabbit model | Q30436846 | ||
Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine. | Q30973103 | ||
Binding of Clostridium difficile toxins to human milk oligosaccharides. | Q33910800 | ||
The role of toxin A and toxin B in Clostridium difficile infection | Q34138233 | ||
Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation | Q34236680 | ||
The role of toxin A and toxin B in the virulence of Clostridium difficile | Q34239367 | ||
p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis | Q34432263 | ||
Comparative sequence analysis of the Clostridium difficile toxins A and B. | Q34435318 | ||
Toxin A-negative, toxin B-positive Clostridium difficile | Q34549681 | ||
Melanin-concentrating hormone (MCH) modulates C difficile toxin A-mediated enteritis in mice | Q34678754 | ||
Structure and mode of action of clostridial glucosylating toxins: the ABCD model | Q34768469 | ||
Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models | Q35669017 | ||
Burden of Clostridium difficile on the healthcare system | Q36071497 | ||
Camera: a competitive gene set test accounting for inter-gene correlation | Q36280584 | ||
IFN-inducible GTPases in host cell defense | Q36374867 | ||
Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure | Q36396899 | ||
Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. | Q36441243 | ||
Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y | Q36958780 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Clostridium difficile | Q310543 |
P304 | page(s) | 3814-3824 | |
P577 | publication date | 2013-07-29 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B | |
P478 | volume | 81 |
Q38208794 | Antibodies for treatment of Clostridium difficile infection |
Q54239070 | Clostridium difficile Toxoid Vaccine Candidate Confers Broad Protection against a Range of Prevalent Circulating Strains in a Nonclinical Setting. |
Q27303623 | Cryptosporidium Priming Is More Effective than Vaccine for Protection against Cryptosporidiosis in a Murine Protein Malnutrition Model |
Q55279053 | Cysteine Protease-Mediated Autocleavage of Clostridium difficile Toxins Regulates Their Proinflammatory Activity. |
Q35676296 | Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections |
Q52653036 | Effects of Clostridium difficile toxin A on K562/A02 cell proliferation, apoptosis and multi-drug resistance. |
Q30276645 | Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A |
Q36189901 | Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis |
Q30300865 | High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types |
Q27026464 | Host recognition of Clostridium difficile and the innate immune response |
Q45068991 | Innate immune response and outcome of Clostridium difficile infection are dependent on fecal bacterial composition in the aged host |
Q34453038 | Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage. |
Q38797967 | Pathogenic effects of glucosyltransferase from Clostridium difficile toxins |
Q36823908 | Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer |
Q54215060 | Structural basis for recognition of frizzled proteins by Clostridium difficile toxin B. |
Q49282081 | The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model |
Q30277264 | Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection |
Q30301156 | Zinc deficiency alters host response and pathogen virulence in a mouse model of enteroaggregative Escherichia coli-induced diarrhea |